Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Oxytocin on Responses to Self vs Other Touch
NCT05899517Unknown
- Sponsor
- University of Electronic Science and Technology of China
- Start
- Jun 2022
- Primary completion
- Jul 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial of oxytocin in Autism Spectrum Disorder (ASD) (2 arms), sponsored by University of Electronic Science and Technology of China. Primary endpoints: fMRI based measures of altered neural activity in response to different types of applied touch and Pleasantness ratings for the different types of applied touch. Status: unknown.
02
Drugs
oxytocin
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT05899517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05899517.